ReportGem ReportGem EN

普通外文研报

Invite: Expert Access – Event: Barclays Hosted Events at ADA 2026: Our Initial Schedule of Meetings and Expert Events

发布日期: 2026-05-20研究机构: Barclays报告页数: 6原文语言: 英语证据页码: 2

研报英文原文证据摘录

Invite: Expert Access – Event: Barclays Hosted Events at ADA 2026: Our Initial Schedule of Meetings and Expert Events

Location TBD

Management Attending:

Peter Rule, Chief Executive Officer

Tom Metzmaker, VP, R&D

Monday, June 8th

KOL Breakfast - Obesity Breakfast Hosted by Emily Field & James Gordon

8:00AM - 9:00AM CT

Stocks in Focus: AZN, AMGN, LLY, NVO, PFE, ROP, ZEAL

KOL Speaker: Vivian A. Fonseca, MD

*More events over the weekend to be announced*

KOL Speaker Bio:

Vivian A. Fonseca, MD, FRCP, is a Professor of Medicine, Assistant Dean for Clinical

Research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the Section of

Endocrinology at Tulane University Medical Center in New Orleans, Louisiana. He is a Past

President for the Science and Medicine of the American Diabetes Association (2012), and

has served on the ADA Board of Directors and several committees. He has served on the

Board of Directors of the American Association of Clinical Endocrinologists (AACE), and the

Board of Trustees of the American College of Endocrinology. He has served on committees

writing guidelines for both organizations, and has held a leadership role, and served on

various committees in several other organizations including the American Board of

Internal Medicine. Dr. Fonseca has served on and been chairman of the clinical practice

committee of the American Diabetes Association, the ADA Disaster Task Force, ADA

strategic planning committee. He has played a significant role in developing guidelines for

treating diabetes (ADA and AACE). He is the Medical Director of the Tulane Clinical Trials

Unit and Director of the Research Professional Development Core, which runs the Masters

in Science in Clinical Research program. Dr. Fonseca’s research interests include the

本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。

打开研报阅读器